HomeCompareOPHLY vs VICI

OPHLY vs VICI: Dividend Comparison 2026

OPHLY yields 3.41% · VICI yields 6.57%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OPHLY wins by $781.59M in total portfolio value
10 years
OPHLY
OPHLY
● Live price
3.41%
Share price
$5.29
Annual div
$0.18
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$782.58M
Annual income
$740,792,960.47
Full OPHLY calculator →
VICI
VICI Properties Inc.
● Live price
6.57%
Share price
$27.12
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$988.8K
Annual income
$623,261.32
Full VICI calculator →

Portfolio growth — OPHLY vs VICI

📍 OPHLY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOPHLYVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OPHLY + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OPHLY pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OPHLY
Annual income on $10K today (after 15% tax)
$289.50/yr
After 10yr DRIP, annual income (after tax)
$629,674,016.40/yr
VICI
Annual income on $10K today (after 15% tax)
$558.67/yr
After 10yr DRIP, annual income (after tax)
$529,772.12/yr
At 15% tax rate, OPHLY beats the other by $629,144,244.28/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OPHLY + VICI for your $10,000?

OPHLY: 50%VICI: 50%
100% VICI50/50100% OPHLY
Portfolio after 10yr
$391.78M
Annual income
$370,708,110.90/yr
Blended yield
94.62%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

OPHLY
Analyst Ratings
2
Sell
Consensus: Sell
Altman Z
5.0
Piotroski
8/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+16.5% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OPHLY buys
0
VICI buys
0
No recent congressional trades found for OPHLY or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOPHLYVICI
Forward yield3.41%6.57%
Annual dividend / share$0.18$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%44.3%
Portfolio after 10y$782.58M$988.8K
Annual income after 10y$740,792,960.47$623,261.32
Total dividends collected$779.53M$948.4K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusSellBuy

Year-by-year: OPHLY vs VICI ($10,000, DRIP)

YearOPHLY PortfolioOPHLY Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$11,381$681.17$11,368$948.43+$13.00OPHLY
2$13,627$1,449.07$13,339$1,493.16+$288.00OPHLY
3$17,824$3,243.01$16,326$2,426.21+$1.5KOPHLY
4$27,000$7,928.61$21,123$4,112.15+$5.9KOPHLY
5$51,340$22,449.56$29,379$7,368.23+$22.0KOPHLY
6$134,722$79,788.74$44,804$14,191.64+$89.9KOPHLY
7$535,510$391,357.72$76,658$29,972.12+$458.9KOPHLY
8$3,480,692$2,907,695.93$150,894$71,015.81+$3.33MOPHLY
9$39,050,210$35,325,869.63$350,814$193,582.47+$38.70MOPHLY
10$782,576,685$740,792,960.47$988,809$623,261.32+$781.59MOPHLY

OPHLY vs VICI: Complete Analysis 2026

OPHLYStock

Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers OPDIVO intravenous infusions for the treatment of malignant tumors; KYPROLIS for intravenous injection; EMEND capsules/PROEMEND intravenous injections for chemotherapy-induced nausea and vomiting; DEMSER capsules for improvement of the symptoms in patients with pheochromocytoma; and MEKTOVI, VELEXBRU, and ADLUMIZ tablets, as well as BRAFTOVI capsules for malignant tumors. The company also provides GLACTIV and FORXIGA tablets for type 2 diabetes; FORXIGA tablets for the treatment of diabetes; ONOACT injections for tachyarrhythmia; OPALMON tablets to treat peripheral circulatory disorder; CORALAN for treatment of chronic heart failure; ORENCIA injections for rheumatoid arthritis; RIVASTACH patches for Alzheimer's disease; ONGENTYS tablets for the treatment of Parkinson's disease; PARSABIV, an intravenous injection for dialysis patients; STAYBLA tablets for overactive bladder; ONON capsules and dry syrups for bronchial asthma and allergic rhinitis; and JOYCLU intra-articular injection for the improvement of joint function, as well as RECALBON tablets for osteoporosis. In addition, it is developing products for esophageal, urothelial carcinoma, Hodgkin's lymphoma, ovarian, bladder, prostate, hepatocellular carcinoma, pancreatic, biliary tract, virus positive/negative solid carcinoma, gastric, esophageal, urothelial, hepatocellular, thyroid, colorectal, melanoma, acute myeloid leukemia, non-small cell lung cancer, primary central nervous system lymphoma, myelodysplastic syndrome, polymyositis/dermatomyositis, tachyarrhythmia, pemphigus, generalized scleroderma, enthesopathy, diabetic polyneuropathy, neurodegenerative, autoimmune, narcolepsy, and thrombosis. The company was founded in 1717 and is headquartered in Osaka, Japan.

Full OPHLY Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this OPHLY vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OPHLY vs SCHDOPHLY vs JEPIOPHLY vs OOPHLY vs KOOPHLY vs MAINOPHLY vs NNNOPHLY vs EPRTOPHLY vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.